Here are relevant reports on : clinical-next-generation-sequencing-ngs-market
-
Enterprise Firewall Market by Types (Next Generation, Application, Conventional), by Appliances, & by Professional Services - Worldwide Forecasts and Analysis (2014 - 2019)
Firewall is a standalone and software-based network device that is used to control, block, and allow the network traffic on the basis of rules and policies set. The enterprise firewall market size, from 2014 to 2019. The market for enterprise firewall is expected to grow from $6.14 billion in 2014 to $8.41 billion in 2019, at a CAGR of 6.49% during the forecast period 2014-2019.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
Next Generation Operations Support System (NGOSS) Transformation Market - Assurance, Fulfillment: Global Worldwide Trends, Adoption and Market Forecasts (2013 - 2018)
In the recent years telecom service providers are divulging into significant transformational projects to enhance business agility and effectiveness.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Advanced Persistent Threat (APT) Protection Market by Offering (Solutions (Sandboxing, Endpoint Protection, SIEM, IDS/IPS, and Next-generation Firewall) and Services), Deployment Mode, Organization Size, Vertical, and Region - Global Forecast to 2025
The Advanced Persistent Threat (APT) Protection Market is expected to grow from USD 5.2 billion in 2020 to USD 12.6 billion by 2025, at a CAGR of 19.5% during the forecast period. The technology vendors covered in the APT protection market report include Broadcom (US), McAfee (US), Kaspersky (Russia), Fortinet (US), FireEye (US), Raytheon Technologies (US), Sophos (UK), ESET (Slovakia), Palo Alto Networks (US), VMware Carbon Black (US), Microsoft (US), Cisco (US), Webroot (US), F-Secure (Finland), Trend Micro (Japan), and CyberArk (US). The start-up vendors covered in the APT protection market report are RevBits (US), Wijungle (India), BluVector (US), Aristi Labs (India), Securden (US), Red Sift (England), ZecOps (US), XM Cyber (Israel). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches and product enhancements, and acquisitions to expand their footprint in the APT protection market.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Next-generation Firewall Market by Offering (Hardware, Software, Services), Deployment Mode (On-premises, Cloud/Virtual), Organization Size (Large Enterprises, SMEs), Vertical (BFSI, Government, Other Verticals) and Region - Global Forecast to 2028
The global Next-generation Firewall Market size is projected to reach USD 8.6 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 11.4% during the forecast period. Palo Alto Networks (US), Cisco (US), Fortinet (US), Check Point (Israel), Juniper Networks (US), Barracuda Networks (US), SonicWall (US), Zscaler (US), Forcepoint (US), Hillstone Networks (US), Versa Networks (US), NordLayer (US), Cato Networks (Israel), CrowdStrike (US), Trend Micro (Japan), Huawei (China), Sophos (UK), Atrity (India), Easi (Belgium), Zyxel Networks (India), Nomios (Netherlands), WatchGuard (US), Sangfor (China), GajShield (India), and H3C (China) are the key players and other players in the next generation firewall market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028
The global RNA analysis market, valued at US$4.8 billion in 2022, stood at US$5.3 billion in 2023 and is projected to advance at a resilient CAGR of 13.4% from 2023 to 2028, culminating in a forecasted valuation of US$9.9 billion by the end of the period. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025
The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031
The global Life Science Instrumentation market, valued at US$59.9 billion in 2024, stood at US$63.4 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2030, culminating in a forecasted valuation of US$92.5 billion by the end of the period. The main drivers of the life science instrumentation market include increasing demand for advanced analytical technologies in drug discovery, genomics, and proteomics research, along with rising investments in pharmaceutical and biotechnology R&D.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S.
- Published: August 2014
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
